Big Pharma Mergers: $84 Billion in Deals in a Quarter https://ymaho.com/big-pharma-mergers-84-billion-in-deals-in-a-quarter
The $300 Billion Patent Cliff Drove Big Pharma to Spend $84 Billion on Biotech Deals in Q1. Find Out Which Companies Are Buying and Why.
M&A in Pharmaceuticals: Deal Boom Due to AI Drug Development https://ymaho.com/m-a-in-pharmaceuticals-deal-boom-due-to-ai-drug-development
Big Pharma spends billions on buying AI startups to shorten the R&D cycle. Learn how AI is changing the M&A market. Detailed analysis.
Phytoceramides vs ceramides: what pharmacy cosmetics hide https://ymaho.com/phytoceramides-vs-ceramides-what-pharmacy-cosmetics-hide
Glycosylceramides provide only 18% barrier restoration compared to 34% for animal ceramides. Find out why 'phytoceramides' are not a replacement. Choose wisely.
Unified FDA and EMA Rules for AI in Pharma https://ymaho.com/unified-fda-and-ema-rules-for-ai-in-pharma
FDA and EMA approved 10 GxP principles for AI in drug development. Learn how the new rules will change the industry and how to prepare for them.
Pharma-biotics: PDRN and exosomes in K-Beauty 2026 https://ymaho.com/pharma-biotics-pdrn-and-exosomes-in-k-beauty-2026
Analysis of the PDRN and exosome boom in Korea: why mass brands are losing, prices 6-10 times lower than procedures, risks and forecasts. Read about the revolution of regenerative care.
French pharmacies: how skincare became a new lifestyle https://ymaho.com/french-pharmacies-how-skincare-became-a-new-lifestyle
Why Generation X spends hours in Parisian pharmacies and concept stores. Discover how 'pharmacy luxury' is changing the market and where to find authenticity. Read the trend analysis.
Korean pharmacies rethink the beauty market: skin care as prevention https://ymaho.com/korean-pharmacies-rethink-the-beauty-market-skin-care-as-prevention
Analytics 2026: pharmacies become new K-Beauty sellers. Why pharmacists are displacing marketers, and prescription care replaces brands. Read forecasts.
Women 45+ and pharma: the women's health market is growing https://ymaho.com/women-45-and-pharma-the-women-s-health-market-is-growing
The women's health market will grow to $55.88 billion in 2026. Learn how pharma companies and Gen X are changing the industry. Read femtech trends.
New EMA recommendations on pharmacovigilance for HIV therapy 2026 https://ymaho.com/new-ema-recommendations-on-pharmacovigilance-for-hiv-therapy-2026
Analysis of new EMA rules for monitoring long-term HIV therapy: risks of INSTI resistance, residual concentrations, risk groups. Read more.
WHO Recommendations on Perimenopause 2026: Non-Pharmacological Methods https://ymaho.com/who-recommendations-on-perimenopause-2026-non-pharmacological-methods
Analysis of New WHO Recommendations from May 20, 2026: Why the Emphasis on CBT and Phytoestrogens Instead of HRT? Who Wins and Who Loses. Read the Forecasts.